Atrium Therapeutics Inc (RNA)

Cash Ratio

2.31

Quarterly · Period ending:

RNA logo

RNA Cash Ratio

Latest reported2.31
RNA Quarterly Cash Ratio (8.51 → 2.31)
High-resolution chart · PNG

RNA cash ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Cash Ratio — Quarterly
Period endingCash Ratio
2.3056
12.2278
6.4592
8.5069
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.